Lawitz EJ, Fraessdorf M, Neff GW, Schattenberg JM, Noureddin M, Alkhouri N, Schmid B, Andrews CP, Takcs I, Hussain SA, Fenske WK, Gane EJ, Hosseini-Tabatabaei A, Sanyal AJ, Mazo DF, Younes R
,
Blood pressure monitoring was particularly intensive because of prior concerns about potential cardiovascular effects associated with similar formulations
It is not approved for human or veterinary use, clinical administration, therapeutic intervention, or diagnostic procedures
While they share a common purpose stimulating the bodys own growth hormone production they differ meaningfully in structure, duration of action, dosing protocols, and clinical applications
[111] treated T2DM patients with exenatide and found that the liver fat content (LFC) of patients decreased from 21.3%19.3% to 12.7%10.6%, a trend that suggested that GLP-1RA drugs could improve liver lipid metabolism